PMDA — authorised 20 September 2019
- Marketing authorisation holder: Meiji Seika Pharma Co., Ltd.
- Status: approved
🇯🇵 Xadago in Japan
PMDA authorised Xadago on 20 September 2019
Marketing authorisation
Xadago in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Japan
Frequently asked questions
Is Xadago approved in Japan?
Yes. PMDA authorised it on 20 September 2019.
Who is the marketing authorisation holder for Xadago in Japan?
Meiji Seika Pharma Co., Ltd. holds the Japanese marketing authorisation.